bosentan (GL PharmTech)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebosentan (GL PharmTech)
Drug Alias Namebosentan
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonistsEndothelin receptor type A antagonists
TargetsEndothelin receptor type AEndothelin receptor type B
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGl Pharm Tech Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGl Pharm Tech Corp
Active IndicationsN/A
Inactive IndicationsPulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A